Paul S. Rennie

University of British Columbia

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers”.

Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers

Cancer Treatment Reviews(2014)10.1016/j.ctrv.2014.10.005

N/A

1.7DataRank · unranked

50 citations

Michael Hsing, Miriam S. Butler, Artem Cherkasov, Paul S. Rennie, Mani Roshan‐Moniri +2 more

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Nature Communications(2019)10.1038/s41467-018-08152-3

N/A

0.817DataRank · unranked

231 citations

Hatice Zeynep Nenseth, Su Qu, Omer F. Kuzu, Turid Frahnow, Lukas M. Simon +12 more

Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Nature Communications(2024)10.1038/s41467-024-50645-x

N/A

0DataRank · unranked

0 citations

Hatice Zeynep Nenseth, Su Qu, Omer F. Kuzu, Turid Frahnow, Lukas M. Simon +12 more

Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer

Scientific Reports(2024)10.1038/s41598-024-57854-w

N/A

0DataRank · unranked

4 citations

Liangliang Liu, Michael Hsing, Kush Dalal, Daksh Thaper, Brian McConeghy +9 more